These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8326381)

  • 1. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.
    Jain D; Wackers FJ; Mattera J; McMahon M; Sinusas AJ; Zaret BL
    J Nucl Med; 1993 Aug; 34(8):1254-9. PubMed ID: 8326381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols.
    Braat SH; Leclercq B; Itti R; Lahiri A; Sridhara B; Rigo P
    J Nucl Med; 1994 Oct; 35(10):1581-5. PubMed ID: 7931653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease.
    Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T
    J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
    Zaret BL; Rigo P; Wackers FJ; Hendel RC; Braat SH; Iskandrian AS; Sridhara BS; Jain D; Itti R; Serafini AN
    Circulation; 1995 Jan; 91(2):313-9. PubMed ID: 7805233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
    Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
    J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
    Hambÿe AS; Delsarte P; Vervaet AM
    Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.
    Sridhara BS; Braat S; Rigo P; Itti R; Cload P; Lahiri A
    Am J Cardiol; 1993 Nov; 72(14):1015-9. PubMed ID: 8213580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined rest thallium-201/stress technetium-99m-tetrofosmin SPECT: feasibility and diagnostic accuracy of a 90-minute protocol.
    Mahmood S; Gunning M; Bomanji JB; Gupta NK; Costa DC; Jarritt PH; Swanton H; Ell PJ
    J Nucl Med; 1995 Jun; 36(6):932-5. PubMed ID: 7769448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
    J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.
    Tamaki N; Takahashi N; Kawamoto M; Torizuka T; Tadamura E; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1994 Apr; 35(4):594-600. PubMed ID: 8151381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m tetrofosmin rest/stress myocardial SPET with a same-day 2-hour protocol: comparison with coronary angiography. A Spanish-Portuguese multicentre clinical trial.
    Montz R; Perez-Castejón MJ; Jurado JA; Martín-Comín J; Esplugues E; Salgado L; Ventosa A; Cantinho G; Sá EP; Fonseca AT; Vieira MR
    Eur J Nucl Med; 1996 Jun; 23(6):639-47. PubMed ID: 8662097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin.
    Takahashi N; Tamaki N; Tadamura E; Kawamoto M; Torizuka T; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J
    J Nucl Cardiol; 1994; 1(1):29-38. PubMed ID: 9420668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin?
    Mann A; Ahlberg AW; White MP; Cross DM; Piriz J; Morris RS; Heller GV
    J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
    Higley B; Smith FW; Smith T; Gemmell HG; Das Gupta P; Gvozdanovic DV; Graham D; Hinge D; Davidson J; Lahiri A
    J Nucl Med; 1993 Jan; 34(1):30-8. PubMed ID: 8418268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
    Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
    J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimum protocol of technetium-99m tetrofosmin myocardial perfusion imaging for the detection of coronary stenosis lesions in Kawasaki disease].
    Karasawa K; Ayusawa M; Noto N; Sumitomo N; Okada T; Harada K
    J Cardiol; 1997 Dec; 30(6):331-9. PubMed ID: 9436075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.